270 related articles for article (PubMed ID: 20570349)
1. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.
Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.
Nowek K; Sun SM; Bullinger L; Bindels EM; Exalto C; Dijkstra MK; van Lom K; Döhner H; Erkeland SJ; Löwenberg B; Jongen-Lavrencic M
Leukemia; 2016 Jan; 30(1):229-37. PubMed ID: 26174629
[TBL] [Abstract][Full Text] [Related]
3. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
[TBL] [Abstract][Full Text] [Related]
4. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
[TBL] [Abstract][Full Text] [Related]
5. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer.
Tsai MM; Wang CS; Tsai CY; Chen CY; Chi HC; Tseng YH; Chung PJ; Lin YH; Chung IH; Chen CY; Lin KH
Cancer Lett; 2014 Sep; 351(2):222-31. PubMed ID: 24933454
[TBL] [Abstract][Full Text] [Related]
7. Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.
Bhatia S; Kaul D; Varma N
Mol Cell Biochem; 2011 Jan; 346(1-2):103-16. PubMed ID: 20924650
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.
Coskun E; Neumann M; Schlee C; Liebertz F; Heesch S; Goekbuget N; Hoelzer D; Baldus CD
Leuk Res; 2013 Jun; 37(6):647-56. PubMed ID: 23522449
[TBL] [Abstract][Full Text] [Related]
10. miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia.
Zhou W; Wang S; Ying Y; Zhou R; Mao P
Oncol Rep; 2017 Feb; 37(2):1075-1083. PubMed ID: 28000876
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic control of differential expression of specific ERG isoforms in acute T-lymphoblastic leukemia.
Bohne A; Schlee C; Mossner M; Thibaut J; Heesch S; Thiel E; Hofmann WK; Baldus CD
Leuk Res; 2009 Jun; 33(6):817-22. PubMed ID: 19108891
[TBL] [Abstract][Full Text] [Related]
12. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
13. Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer.
Lu YC; Chang JT; Huang YC; Huang CC; Chen WH; Lee LY; Huang BS; Chen YJ; Li HF; Cheng AJ
Clin Biochem; 2015 Feb; 48(3):115-21. PubMed ID: 25485932
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circCRKL inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p/miR-196b-5p/p27 axis.
Liu W; Cheng F
Bioengineered; 2021 Dec; 12(1):7704-7713. PubMed ID: 34617876
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
[TBL] [Abstract][Full Text] [Related]
16. Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas.
Zhang C; Yao C; Li H; Wang G; He X
Int J Mol Sci; 2014 Apr; 15(4):6544-55. PubMed ID: 24747591
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
Marcucci G; Baldus CD; Ruppert AS; Radmacher MD; Mrózek K; Whitman SP; Kolitz JE; Edwards CG; Vardiman JW; Powell BL; Baer MR; Moore JO; Perrotti D; Caligiuri MA; Carroll AJ; Larson RA; de la Chapelle A; Bloomfield CD
J Clin Oncol; 2005 Dec; 23(36):9234-42. PubMed ID: 16275934
[TBL] [Abstract][Full Text] [Related]
18. BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Schwind S; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Holland KB; Margeson D; Becker H; Whitman SP; Wu YZ; Metzeler KH; Powell BL; Kolitz JE; Carter TH; Moore JO; Baer MR; Carroll AJ; Caligiuri MA; Larson RA; Bloomfield CD
Blood; 2010 Dec; 116(25):5660-9. PubMed ID: 20841507
[TBL] [Abstract][Full Text] [Related]
19. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
20. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
